Scientific Programme - 11th European Multidisciplinary Congress on Urological Cancers (EMUC19)

View programme as: Grid view List view
Print: Print
Personal Planner

06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00

Room K2
Room 0.12
Foyer
Auditorium
Room G1
Room G2
Room K1

1. 06:00
2. 07:00
3. 08:00
4. 09:00
5. 10:00
6. 11:00
7. 12:00
8. 13:00
9. 14:00
10. 15:00
11. 16:00
12. 17:00
13. 18:00
14. 19:00
15. 20:00
16. 21:00
Auditorium
1. Plenary Session 07 - New trials update
  
  New trials update Plenary Session 07
  
  08:00 - 09:45
  New trials update
  
  Plenary Session 07
  
  Sat 16 November
  08:00 - 09:45
  
  Location:
  
  Auditorium
  
  Chairs:
  
  C. Salembier, Brussels (BE)
  A. Bamias, Athens (GR)
  T. Maurer, Hamburg (DE)
  
  08:00 - 08:15
  
  The SPCG4 study
  
  Speaker :
  
  To be confirmed
  
  Discussant :
  
  L.H. Klotz, Toronto (CA)
  
  08:15 - 08:30
  
  The ARAMIS trial
  
  Speaker :
  
  K. Fizazi, Villejuif (FR)
  
  Discussant :
  
  To be confirmed
  
  08:30 - 08:45
  
  KEYNOTE 057
  
  Speaker :
  
  A.V. Balar, ()
  
  Discussant :
  
  A.M. Kamat, Houston (US)
  
  08:45 - 09:00
  
  Metastatic RCC: First line treatment
  
  Speaker :
  
  M. Schmidinger, Vienna (AT)
  
  Discussant :
  
  M-O. Grimm, Jena (DE)
  
  09:00 - 09:15
  
  Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized phase III trial
  
  Speaker :
  
  To be confirmed
  
  Discussant :
  
  P. Hoskin, Northwood (GB)
  
  09:15 - 09:45
  
  Discussion
2. Welcome and introduction
  
  Welcome and introduction
  
  08:30 - 08:40
  Welcome and introduction
  
  Fri 15 November
  08:30 - 08:40
  
  Location:
  
  Auditorium
  
  Chairs:
  
  L. Albiges, Villejuif (FR)
  P. Hoskin, Northwood (GB)
  H.P.A.M. Van Poppel, Leuven (BE)
3. Plenary Session 15 - Announcement 3 best unmoderated posters
  
  Announcement 3 best unmoderated posters Plenary Session 15
  
  08:30 - 08:45
  Announcement 3 best unmoderated posters
  
  Plenary Session 15
  
  Sun 17 November
  08:30 - 08:45
  
  Location:
  
  Auditorium
  
  Chairs:
  
  P. Bono, Helsinki (FI)
  B. De Bari, Besancon (FR)
  R.J.A. Van Moorselaar, Amsterdam (NL)
4. Early detection of prostate cancer 40 years later. The 40th birthday of PSA
  
  •
  
  Early detection of prostate cancer 40 years later. The 40th birthday of PSA
  
  08:40 - 10:30
  Early detection of prostate cancer 40 years later. The 40th birthday of PSA
  
  Fri 15 November
  08:40 - 10:30
  
  Location:
  
  Auditorium
  
  Chairs:
  
  T. Wiegel, Ulm (DE)
  R. Oyen, Leuven (BE)
  E. Compérat, Paris (FR)
  C.H. Bangma, Rotterdam (NL)
  
  08:40 - 08:45
  
  PSA screening has to come back
  
  H.P.A.M. Van Poppel, Leuven (BE)
  
  08:45 - 08:55
  
  The story of PSA
  
  M. Roobol, Rotterdam (NL)
  
  08:55 - 09:05
  
  Early detection in prostate cancer in 2019
  
  P. Albers, Düsseldorf (DE)
  
  09:05 - 09:15
  
  Prostate cancer screening by MRI: Will it ever happen?
  
  H. Thoeny, Bern (CH)
  
  09:15 - 09:25
  
  Prostate cancer morphology: Major changes with clinical significance in the last 40 years
  
  R. Montironi, Ancona (IT)
  
  09:25 - 09:40
  
  Discussion
  
  09:40 - 09:50
  
  Biomarkers for early detection: Real game changers?
  
  G. Jenster, Rotterdam (NL)
  
  09:50 - 10:00
  
  Medical application of prostate cancer genomics
  
  M.A. Rubin, Berne (CH)
  
  10:00 - 10:30
  
  Discussion
5. Plenary Session 16
  
  • Pathology in active surveillance
  
  Pathology in active surveillance: Update and controversies Plenary Session 16
  
  08:45 - 09:15
  Pathology in active surveillance: Update and controversies
  
  Plenary Session 16
  
  Sun 17 November
  08:45 - 09:15
  
  Location:
  
  Auditorium
  
  Chair:
  
  R. Montironi, Ancona (IT)
  
  Discussant:
  
  A. Briganti, Milan (IT)
  
  08:45 - 09:05
  
  Pathology in active surveillance
  
  J. Epstein, Baltimore (US)
6. Debate - Treatment of metastatic prostate cancer
  
  Treatment of metastatic prostate cancer Debate
  
  09:15 - 10:35
  Treatment of metastatic prostate cancer
  
  Debate
  
  Sun 17 November
  09:15 - 10:35
  
  Location:
  
  Auditorium
  
  Chairs:
  
  P. Ost, Ghent (BE)
  S. Joniau, Leuven (BE)
  S. Gillessen Sommer, ()
  
  09:15 - 10:00
  
  Best treatment in de novo metastatic disease
  
  09:15 - 09:25
  
  Docetaxel
  
  S. Bracarda, Terni (IT)
  
  09:25 - 09:35
  
  Abiraterone
  
  P. Cornford, Liverpool (GB)
  
  09:35 - 09:45
  
  When to add local treatment
  
  R. Sanchez-Salas, Paris (FR)
  
  09:45 - 10:00
  
  Discussion
  
  10:00 - 10:35
  
  Oligometastatic recurrence - Imaging guided therapy
  
  10:00 - 10:10
  
  Yes
  
  G. De Meerleer, Leuven (BE)
  
  10:10 - 10:20
  
  No
  
  N. Mottet, Saint-Étienne (FR)
  
  10:20 - 10:35
  
  Discussion
7. Plenary Session 08 - Announcement 3 best unmoderated posters
  
  Announcement 3 best unmoderated posters Plenary Session 08
  
  09:45 - 10:00
  Announcement 3 best unmoderated posters
  
  Plenary Session 08
  
  Sat 16 November
  09:45 - 10:00
  
  Location:
  
  Auditorium
  
  Chairs:
  
  L. Albiges, Villejuif (FR)
  V. Fonteyne, Ghent (BE)
  To be confirmed
8. Multidisciplinary case discussion - Residual disease after chemotherapy in testicular cancer
  
  Residual disease after chemotherapy in testicular cancer Multidisciplinary case discussion
  
  10:30 - 11:00
  Residual disease after chemotherapy in testicular cancer
  
  Multidisciplinary case discussion
  
  Sat 16 November
  10:30 - 11:00
  
  Location:
  
  Auditorium
  
  Case presenter:
  
  C. Oing, ()
  
  Discussants:
  
  A. Heidenreich, Cologne (DE)
  J. Oldenburg, Lørenskog (NO)
  F. Giammarile, ()
  G. De Meerleer, Leuven (BE)
  L. Rocher, Paris (FR)
9. EU Joint Action (Innovative Partnership for Action Against Cancer IPAAC)
  
  EU Joint Action (Innovative Partnership for Action Against Cancer IPAAC)
  
  10:35 - 10:50
  EU Joint Action (Innovative Partnership for Action Against Cancer IPAAC)
  
  Sun 17 November
  10:35 - 10:50
  
  Location:
  
  Auditorium
  
  Chair:
  
  To be confirmed
  
  10:35 - 10:50
  
  EU Joint Action (Innovative Partnership for Action Against Cancer IPAAC)
  
  T. Albreht, Ljubljana (SI)
10. Plenary Session 19 - Take home messages
  
  Take home messages Plenary Session 19
  
  10:50 - 11:40
  Take home messages
  
  Plenary Session 19
  
  Sun 17 November
  10:50 - 11:40
  
  Location:
  
  Auditorium
  
  10:50 - 11:40
  
  Take home messages
  
  10:50 - 11:00
  
  Take home message
  
  R. Montironi, Ancona (IT)
  
  11:00 - 11:10
  
  Take home message
  
  C. Salembier, Brussels (BE)
  
  11:10 - 11:20
  
  Take home message
  
  A. Briganti, Milan (IT)
  
  11:20 - 11:30
  
  Take home message
  
  R. Oyen, Leuven (BE)
  
  11:30 - 11:40
  
  Take home message
  
  A. Bamias, Athens (GR)
11. Multidisciplinary case discussion - Prostate cancer: From active surveillance to active treatment
  
  Prostate cancer: From active surveillance to active treatment Multidisciplinary case discussion
  
  11:00 - 12:00
  Prostate cancer: From active surveillance to active treatment
  
  Multidisciplinary case discussion
  
  Fri 15 November
  11:00 - 12:00
  
  Location:
  
  Auditorium
  
  Chairs:
  
  B. De Bari, Besancon (FR)
  G.N. Thalmann, Bern (CH)
  
  Case presenter:
  
  J-E. Bibault, ()
  
  11:00 - 12:00
  
  Multidisciplinary case discussion From active surveillance to active treatment
  
  Case presenter :
  
  G. Ploussard, Toulouse (FR)
  
  Discussants :
  
  F. Montorsi, Milan (IT)
  
  T. Gevaert, Kluisbergen (BE)
  
  A. Bossi, Villejuif (FR)
  
  R. Renard-Penna, Paris (FR)
  
  L.H. Klotz, Toronto (CA)
12. Plenary Session 10 - Late breaking news session
  
  Late breaking news session Plenary Session 10
  
  11:00 - 11:20
  Late breaking news session
  
  Plenary Session 10
  
  Sat 16 November
  11:00 - 11:20
  
  Location:
  
  Auditorium
  
  Chairs:
  
  L. Albiges, Villejuif (FR)
  E. Xylinas, Paris (FR)
  
  11:00 - 11:10
  
  Update of the IGCCCG classification
  
  S. Gillessen Sommer, ()
  
  11:10 - 11:20
  
  The OLYMPUS study: Optimised DeLivery of Mutomicin for Primary UTUC study
  
  To be confirmed
13. Plenary Session 11 - False positives findings in uro-oncology and their clinical impact
  
  False positives findings in uro-oncology and their clinical impact Plenary Session 11
  
  11:20 - 12:00
  False positives findings in uro-oncology and their clinical impact
  
  Plenary Session 11
  
  Sat 16 November
  11:20 - 12:00
  
  Location:
  
  Auditorium
  
  Chairs:
  
  I.J. De Jong, Groningen (NL)
  H. Thoeny, Bern (CH)
  A. Bossi, Villejuif (FR)
  
  11:20 - 11:30
  
  Imaging: PSMA PET
  
  D. Deandreis, ()
  
  11:30 - 11:40
  
  Imaging: MRI of the prostate
  
  R. Renard-Penna, Paris (FR)
  
  11:40 - 11:50
  
  False positive results in pathology
  
  F. Algaba, Barcelona (ES)
  
  11:50 - 12:00
  
  Discussion
14. Closing remarks
  
  Closing remarks
  
  11:40 - 11:50
  Closing remarks
  
  Sun 17 November
  11:40 - 11:50
  
  Location:
  
  Auditorium
  
  Chairs:
  
  L. Albiges, Villejuif (FR)
  P. Hoskin, Northwood (GB)
  H.P.A.M. Van Poppel, Leuven (BE)
15. Plenary Session 03 - Highlights in GU cancers
  
  Highlights in GU cancers Plenary Session 03
  
  12:00 - 12:30
  Highlights in GU cancers
  
  Plenary Session 03
  
  Fri 15 November
  12:00 - 12:30
  
  Location:
  
  Auditorium
  
  Chairs:
  
  J. Walz, Marseille (FR)
  R. Oyen, Leuven (BE)
  
  12:00 - 12:10
  
  Results of the APCCC meeting
  
  To be confirmed
  
  12:10 - 12:20
  
  Highlights from ESUI
  
  G. Salomon, Hamburg (DE)
  
  12:20 - 12:30
  
  The EAU Research Foundation: Trials in progress
  
  A.S. Bjartell, Malmö (SE)
16. Plenary Session 12 - Oral presentation of the 6 best abstracts
  
  Oral presentation of the 6 best abstracts Plenary Session 12
  
  12:00 - 12:40
  Oral presentation of the 6 best abstracts
  
  Plenary Session 12
  
  Sat 16 November
  12:00 - 12:40
  
  Location:
  
  Auditorium
  
  Chairs:
  
  A. Bamias, Athens (GR)
  C. Salembier, Brussels (BE)
  A. Briganti, Milan (IT)
17. Novelties in non-muscle invasive bladder cancer
  
  Novelties in non-muscle invasive bladder cancer
  
  14:00 - 15:15
  Novelties in non-muscle invasive bladder cancer
  
  Fri 15 November
  14:00 - 15:15
  
  Location:
  
  Auditorium
  
  Chairs:
  
  A. Necchi, Milan (IT)
  M. Rouprêt, Paris (FR)
  G. Mikuz, Innsbruck (AT)
  
  14:00 - 14:15
  
  VI-RADS for the management of non-muscle-invasive bladder cancer
  
  V. Panebianco, Rome (IT)
  
  14:15 - 14:30
  
  Intravesical alternatives for non-muscle-invasive bladder cancer treatment
  
  A.M. Kamat, Houston (US)
  
  14:30 - 14:40
  
  Novel biomarkers - urinary markers for in non-muscle-invasive bladder cancer
  
  L. Dyrskjøt, Aarhus (DK)
  
  14:40 - 14:55
  
  Morphological changes after therapy
  
  A. Lopez-Beltran, Lisbon (PT)
  
  14:55 - 15:15
  
  Discussion
18. Plenary Session 13 - Small renal masses in patients with different comorbidity profiles
  
  Small renal masses in patients with different comorbidity profiles Plenary Session 13
  
  14:00 - 16:00
  Small renal masses in patients with different comorbidity profiles
  
  Plenary Session 13
  
  Sat 16 November
  14:00 - 16:00
  
  Location:
  
  Auditorium
  
  Chairs:
  
  H.P.A.M. Van Poppel, Leuven (BE)
  K. Junker, Homburg (DE)
  B. Vanneste, Maastricht (NL)
  
  14:00 - 14:10
  
  Case presentation (including voting, 2 cases)
  
  A. Larcher, Milan (IT)
  
  14:10 - 14:25
  
  How to do active surveillance?
  
  A. Volpe, Novara (IT)
  
  14:25 - 14:40
  
  Surgery, focal: What to do when?
  
  A. Finelli, Toronto (CA)
  
  14:40 - 14:55
  
  Stereotactic body radiotherapy (SBRT) for kidney cancer
  
  B. Vanneste, Maastricht (NL)
  
  14:55 - 15:10
  
  Contrast-enhanced ultrasound
  
  To be confirmed
  
  15:10 - 15:25
  
  Histological and molecular differentiation of small renal masses
  
  K. Junker, Homburg (DE)
  
  15:25 - 16:00
  
  Discussion and conclusion on cases (including voting)
19. Nightmare session: It could happen to you…
  
  Nightmare session: It could happen to you…
  
  15:15 - 15:45
  Nightmare session: It could happen to you…
  
  Fri 15 November
  15:15 - 15:45
  
  Location:
  
  Auditorium
  
  Chairs:
  
  C. Cozzarini, Milan (IT)
  A. Stenzl, Tübingen (DE)
  
  15:15 - 15:25
  
  Surgery
  
  R. Sanchez-Salas, Paris (FR)
  
  15:25 - 15:30
  
  Discussion
  
  15:30 - 15:40
  
  Radiation therapy
  
  T. Wiegel, Ulm (DE)
  
  15:40 - 15:45
  
  Discussion
20. Challenge the expert
  
  • Complete response after neoadjuvant chemotherapy or immunotherapy
  • Histological variants in non-muscle invasive bladder cancer
  • Upper tract recurrence after cystectomy
  
  Challenge the expert
  
  16:15 - 17:30
  Challenge the expert
  
  Fri 15 November
  16:15 - 17:30
  
  Location:
  
  Auditorium
  
  Discussants:
  
  M. De Santis, Berlin (DE)
  S. Shariat, Vienna (AT)
  To be confirmed
  R. Renard-Penna, Paris (FR)
  M. Fiorentino, Bologna (IT)
  
  16:15 - 16:40
  
  Multidisciplinary case discussion Complete response after neoadjuvant chemotherapy or immunotherapy
  
  To be confirmed
  
  16:40 - 17:05
  
  Multidisciplinary case discussion Histological variants in non-muscle invasive bladder cancer
  
  M. Moschini, Luzern (CH)
  
  17:05 - 17:30
  
  Multidisciplinary case discussion Upper tract recurrence after cystectomy
  
  B.M. Kiss, Bern (CH)
21. Plenary Session 14 - Combined treatment with immunotherapy
  
  Combined treatment with immunotherapy Plenary Session 14
  
  16:30 - 17:30
  Combined treatment with immunotherapy
  
  Plenary Session 14
  
  Sat 16 November
  16:30 - 17:30
  
  Location:
  
  Auditorium
  
  Chairs:
  
  B. De Bari, Besancon (FR)
  A. Bex, London (GB)
  M. Schmidinger, Vienna (AT)
  
  16:30 - 16:45
  
  Immunotherapy and radiotherapy
  
  A.R. Filippi, Pavia (IT)
  
  16:45 - 17:00
  
  Immunotherapy and systemic treatment
  
  T. Powles, London (GB)
  
  17:00 - 17:15
  
  Peri-operative immunotherapy in 2019
  
  J. Bedke, Tübingen (DE)
  
  17:15 - 17:30
  
  Discussion
Room G2
1. EAU Section Uro-Pathology (ESUP) Symposium, jointly organized with EAU Section Urological Research (ESUR) and European Society of Pathology Uropathology Working Group - Current applications and future perspectives of liquid biopsies in Uro-Oncology
  
  Current applications and future perspectives of liquid biopsies in Uro-Oncology EAU Section Uro-Pathology (ESUP) Symposium, jointly organized with EAU Section Urological Research (ESUR) and European Society of Pathology Uropathology Working Group
  
  13:30 - 16:30
  Current applications and future perspectives of liquid biopsies in Uro-Oncology
  
  EAU Section Uro-Pathology (ESUP) Symposium, jointly organized with EAU Section Urological Research (ESUR) and European Society of Pathology Uropathology Working Group
  
  Thu 14 November
  13:30 - 16:30
  
  Location:
  
  Room G2
  
  Chairs:
  
  R. Montironi, Ancona (IT)
  A. Lopez-Beltran, Lisbon (PT)
  K. Junker, Homburg (DE)
  H.P.A.M. Van Poppel, Leuven (BE)
  
  13:30 - 13:35
  
  Introduction
  
  H.P.A.M. Van Poppel, Leuven (BE)
  
  13:35 - 14:00
  
  Current applications of liquid biopsies: What we need to know before starting using them?
  
  M. Fiorentino, Bologna (IT)
  
  14:00 - 14:25
  
  Molecular characterization and diagnostic criteria of kidney cancer with emphasis on liquid biopsies
  
  K. Junker, Homburg (DE)
  
  14:25 - 14:50
  
  An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies
  
  F. Massari, Bologna (IT)
  
  14:50 - 15:15
  
  Liquid biopsies and bladder cancer
  
  T. Gevaert, Leuven (BE)
  
  15:15 - 15:40
  
  Current bladder cancer biomarkers with emphasis on urine biomarkers
  
  A. Lopez-Beltran, Lisbon (PT)
  
  15:40 - 16:05
  
  Future perspectives of liquid biopsies in Uro-Oncology
  
  S. Riethdorf, Hamburg (DE)
  
  16:05 - 16:30
  
  Discussion and conclusions
  
  R. Montironi, Ancona (IT)
2. Uropathology Course on “Joint histological evaluation of the specimens by the uropathologist and the clinician: Together we can do it better - Morphologic and molecular classification of bladder cancer
  
  Morphologic and molecular classification of bladder cancer Uropathology Course on “Joint histological evaluation of the specimens by the uropathologist and the clinician: Together we can do it better
  
  16:45 - 17:45
  Morphologic and molecular classification of bladder cancer
  
  Uropathology Course on “Joint histological evaluation of the specimens by the uropathologist and the clinician: Together we can do it better
  
  Thu 14 November
  16:45 - 17:45
  
  Location:
  
  Room G2
  
  Chairs:
  
  R. Montironi, Ancona (IT)
  A. Lopez-Beltran, Lisbon (PT)
  D. Ertoy Baydar, Istanbul (TR)
  
  Aims and objectives of this session
  
  The joint histological evaluation of specimens of bladder and prostate cancer by the clinician and uropathologist can produce much more clinical and prognostic information than that contained in the final histopathology report. Both the clinician and uropathologist can benefit from such an approach. The former will more clearly understand and explain the preoperative features of the cancer, the intraoperative findings, and postoperative follow-up of the patient. The experience acquired would help improve him/her diagnostic and prognostication capabilities and surgical skill. The uropathologist will learn the great clinical significance of his/her daily routine. The course will be based on the projection and discussion of virtual slides.
Room K1
1. ESU Course 01 - Oligometastases in genito urinary cancers
  
  Oligometastases in genito urinary cancers ESU Course 01
  
  09:00 - 12:00
  Oligometastases in genito urinary cancers
  
  ESU Course 01
  
  Thu 14 November
  09:00 - 12:00
  
  Location:
  
  Room K1
  
  Chair:
  
  H.G. Van Der Poel, Amsterdam (NL)
  
  09:00 - 09:05
  
  European School of Urology: A unique possibility for urological education
  
  H.G. Van Der Poel, Amsterdam (NL)
  
  09:05 - 09:10
  
  Introduction and aims
  
  09:10 - 09:40
  
  Definitions and biology of oligometastases
  
  H.G. Van Der Poel, Amsterdam (NL)
  
  09:40 - 10:10
  
  Role of imaging modalities
  
  T. Maurer, Hamburg (DE)
  
  10:10 - 10:30
  
  Break
  
  10:30 - 11:00
  
  Radiotherapeutic management of oligometastases in prostate cancer
  
  G. De Meerleer, Leuven (BE)
  
  11:00 - 11:30
  
  Salvage surgical treatment of nodal metastases
  
  T. Maurer, Hamburg (DE)
  
  11:30 - 11:55
  
  Role of systemic therapy in oligometastasized disease
  
  H.G. Van Der Poel, Amsterdam (NL)
  
  11:55 - 12:00
  
  Take home messages and close
2. ESU Course 02 - Immunotherapy for urological tumours
  
  Immunotherapy for urological tumours ESU Course 02
  
  14:00 - 17:00
  Immunotherapy for urological tumours
  
  ESU Course 02
  
  Thu 14 November
  14:00 - 17:00
  
  Location:
  
  Room K1
  
  Chair:
  
  R.J.A. Van Moorselaar, Amsterdam (NL)
  
  14:00 - 14:05
  
  European School of Urology: A unique possibility for urological education
  
  R.J.A. Van Moorselaar, Amsterdam (NL)
  
  14:05 - 14:25
  
  Update and current knowledge of immunotherapy in prostate cancer
  
  A. Necchi, Milan (IT)
  
  14:25 - 14:55
  
  Immunotherapy for urological tumours: Clinical cases in prostate cancer
  
  A. Necchi, Milan (IT)
  
  14:55 - 15:15
  
  Break
  
  15:15 - 15:35
  
  Update and current knowledge of immunotherapy in renal cancer
  
  R.J.A. Van Moorselaar, Amsterdam (NL)
  
  15:35 - 16:05
  
  Immunotherapy for urological tumours: Clinical cases in renal cancer
  
  M-O. Grimm, Jena (DE)
  
  16:05 - 16:25
  
  Update and current knowledge of immunotherapy in bladder cancer
  
  T. Powles, London (GB)
  
  16:25 - 16:55
  
  Immunotherapy for urological tumours: Clinical cases in bladder cancer
  
  T. Powles, London (GB)
  
  16:55 - 17:00
  
  Closing remarks
Room 0.12
1. FALCON - Pelvic nodal irradiation : Any news in the the new era of imaging?
  
  Pelvic nodal irradiation : Any news in the the new era of imaging? FALCON
  
  14:00 - 16:00
  Pelvic nodal irradiation : Any news in the the new era of imaging?
  
  FALCON
  
  Sat 16 November
  14:00 - 16:00
  
  Location:
  
  Room 0.12
  
  Chairs:
  
  B. De Bari, Besancon (FR)
  F. Giammarile, ()
  F. Alongi, Verona (IT)
Room K2
1. YAU Meeting - YAU Autumn Meeting
  
  YAU Autumn Meeting YAU Meeting
  
  13:00 - 18:00
  YAU Autumn Meeting
  
  YAU Meeting
  
  Thu 14 November
  13:00 - 18:00
  
  Location:
  
  Room K2
  
  Moderators:
  
  To be confirmed
  To be confirmed
Room G1
1. ESUI Meeting - 8th Meeting of the EAU Section of Urological Imaging
  
  8th Meeting of the EAU Section of Urological Imaging ESUI Meeting
  
  08:30 - 18:00
  8th Meeting of the EAU Section of Urological Imaging
  
  ESUI Meeting
  
  Thu 14 November
  08:30 - 18:00
  
  Location:
  
  Room G1
Foyer
1. Coffee break and poster viewing
  
  Coffee break and poster viewing
  
  10:00 - 10:30
  Coffee break and poster viewing
  
  Sat 16 November
  10:00 - 10:30
  
  Location:
  
  Foyer
2. Coffee break and poster viewing
  
  Coffee break and poster viewing
  
  10:30 - 11:00
  Coffee break and poster viewing
  
  Fri 15 November
  10:30 - 11:00
  
  Location:
  
  Foyer
3. Lunch break and poster viewing
  
  Lunch break and poster viewing
  
  12:30 - 14:00
  Lunch break and poster viewing
  
  Fri 15 November
  12:30 - 14:00
  
  Location:
  
  Foyer
4. Lunch break and poster viewing
  
  Lunch break and poster viewing
  
  12:40 - 14:00
  Lunch break and poster viewing
  
  Sat 16 November
  12:40 - 14:00
  
  Location:
  
  Foyer
5. Coffee break and poster viewing
  
  Coffee break and poster viewing
  
  15:45 - 16:15
  Coffee break and poster viewing
  
  Fri 15 November
  15:45 - 16:15
  
  Location:
  
  Foyer
6. Coffee break and poster viewing
  
  Coffee break and poster viewing
  
  16:00 - 16:30
  Coffee break and poster viewing
  
  Sat 16 November
  16:00 - 16:30
  
  Location:
  
  Foyer

Room K2

Room 0.12

Foyer

Auditorium

Room G1

Room G2

Room K1

Auditorium

Room G2

Room K1

Room 0.12

Room K2

Room G1

Foyer